These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3616473)

  • 1. [Dynamic test of hypocalcemia induced by calcitonin as a mean of global evaluation of osteoclastic activity in vivo. A new method of interpretation and results in the breakdown of osteoporosis].
    Colson F; Gioud M; Tebib JG; Mathieu M; Bouvier M
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):481-6. PubMed ID: 3616473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of osteoclastic activity in multiple myeloma: results of a randomized trial studying hypocalcemia induced by human and salmon calcitonin in 49 patients].
    Fuzibet JG; Lejeune C; Lepeu G; Jaubert J; Sotto JJ; Peyron R
    Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):223-7. PubMed ID: 2057701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocalcemia response following calcitonin administration: lack of correlation with osteoclast number determined after histoenzymologic identification in osteoporosis.
    Palle S; Chappard D; Vico L; Alexandre C
    Clin Rheumatol; 1988 Sep; 7(3):354-8. PubMed ID: 3229081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Letter: The calcitonin induced acute hypocalcemia test].
    Fournie A; Valverde C; Tap G; Ayrolles C
    Nouv Presse Med; 1976 May; 5(22):1429. PubMed ID: 934867
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Thompson ER; Chesnut CH; Baylink DJ
    Miner Electrolyte Metab; 1986; 12(4):246-54. PubMed ID: 3762511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of osteoclasts and osteocytes in compact human bone at various ages, both with and without osteoporosis.
    Muglia MA; Volpi G; Remaggi F; Canè V; Palazzini S; Zaffe D; Marotti G
    Ital J Orthop Traumatol; 1982 Mar; 8(1):117-25. PubMed ID: 7174280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The calcitonin-induced hypocalcemia test. For a simplified protocol].
    Eisinger J
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):439-40. PubMed ID: 6494783
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bone in hepatic cirrhosis: morphometric and biological study (author's transl)].
    Le Charpentier Y; Patri B; Dubrisay J; Forest M; Daudet-Monsac M; Carlioz A; Abelanet R
    Sem Hop; 1979 Jun 8-15; 55(21-22):1101-4. PubMed ID: 225817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.
    Gough A; Sambrook P; Devlin J; Huissoon A; Njeh C; Robbins S; Nguyen T; Emery P
    J Rheumatol; 1998 Jul; 25(7):1282-9. PubMed ID: 9676757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of the bone destroying activity of osteocytes and osteoclasts in experimental disuse osteoporosis.
    Marotti G; Delrio N; Marotti F; Fadda M
    Ital J Orthop Traumatol; 1979 Aug; 5(2):225-40. PubMed ID: 548516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients.
    Bataille R; Legendre C; Sany J
    J Clin Oncol; 1985 Feb; 3(2):229-36. PubMed ID: 3968553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural evaluation of bone cells in pigs with experimental turbinate osteoporosis (atrophic rhinitis).
    Fetter AW; Capen CC
    Lab Invest; 1971 May; 24(5):392-403. PubMed ID: 5088260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quantitative histological study of osteoclastic resorption in primary and secondary hyperparathyroidism].
    Meunier P; Vignon G; Vauzelle JL; Zech P
    Pathol Biol (Paris); 1969 Nov; 17(21):927-38. PubMed ID: 4907648
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis. Postmenopausal or secondary?
    Frame B; McKenna MJ
    Hosp Pract (Off Ed); 1985 Oct; 20(10A):37-46. PubMed ID: 3932378
    [No Abstract]   [Full Text] [Related]  

  • 16. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT; Kawatani M; Kato M; Shinki T; Yonezawa T; Kanoh N; Nakagawa H; Takami M; Lee KH; Stern PH; Nagai K; Osada H
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4729-34. PubMed ID: 16537392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathology of osteoporosis in the young adult].
    Bordier P; de Sèze S; Miravet L; Berbir N
    Sem Hop; 1974 Jan; 50(3):197-206. PubMed ID: 4367925
    [No Abstract]   [Full Text] [Related]  

  • 19. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
    Sugawara K; Hamada M; Hosoi S; Tamaoki T
    Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.